Convergent transcriptomic and genomic evidence supporting a dysregulation of CXCL16 and CCL5 in Alzheimer's disease. Alzforum, 27 Jan 2023 Li X, Zhang DF, Bi R, Tan LW, Chen X, Xu M, Yao YG. Alzheimers Res Ther. 2023 Jan 21;15(1):17.